X0202 SCHEDULE 13G 0001732768 XXXXXXXX LIVE Common Stock, $0.001 Par Value 08/28/2026 0001179929 MOLINA HEALTHCARE, INC. 60855R100 200 Oceangate Suite 100 Long Beach CA 90802 Rule 13d-1(c) Giovanni Agnelli B.V. P7 2718348.00 0.00 2718348.00 0.00 2718348.00 N 5.21 HC CO Exor N.V. P7 2718348.00 0.00 2718348.00 0.00 2718348.00 N 5.21 HC CO Lingotto Investment Management (UK) Limited X0 2718348.00 0.00 2718348.00 0.00 2718348.00 N 5.21 CO FI Lingotto Investment Management LLP X0 2718348.00 0.00 2718348.00 0.00 2718348.00 N 5.21 PN FI MOLINA HEALTHCARE, INC. 200 Oceangate, Suite 100, Long Beach,CA 90802 Giovanni Agnelli B.V. Exor N.V. Lingotto Investment Management (UK) Limited Lingotto Investment Management LLP Lingotto Investment Management LLP, which acquired the securities being reported on, is 99.7% owned by Lingotto Investment Management (UK) Limited. Lingotto Investment Management (UK) Limited is a wholly owned subsidiary of Exor N.V., which in turn is controlled by Giovanni Agnelli B.V. Giovanni Agnelli B.V. Hildegard von Bingenstraat 38 1081 LH Amsterdam The Netherlands Exor N.V. Hildegard von Bingenstraat 38 1081 LH Amsterdam The Netherlands Lingotto Investment Management (UK) Limited 7 Seymour Street London, W1H 7JW United Kingdom Lingotto Investment Management LLP 7 Seymour Street London, W1H 7JW United Kingdom Giovanni Agnelli B.V. - the Netherlands Exor N.V. - the Netherlands Lingotto Investment Management (UK) Limited- United Kingdom Lingotto Investment Management LLP - United Kingdom Y See the responses to Item 9 on the attached cover pages. See the responses to Item 11 on the attached cover pages. See the responses to Item 5 on the attached cover pages. See the responses to Item 6 on the attached cover pages. See the responses to Item 7 on the attached cover pages. See the responses to Item 8 on the attached cover pages. Y Y N See Item 2 Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Percent of class based on 52,200,000 common shares outstanding, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on 23 July 2026. Giovanni Agnelli B.V. /s/ Guido de Boer 09/03/2026 Exor N.V. /s/ Guido de Boer 09/03/2026 Lingotto Investment Management (UK) Limited /s/ Enrico Vellano 09/03/2026 Lingotto Investment Management LLP /s/ Enrico Vellano 09/03/2026